These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 10509924)

  • 21. Preclinical pharmacology of bilastine, a new selective histamine H1 receptor antagonist: receptor selectivity and in vitro antihistaminic activity.
    Corcóstegui R; Labeaga L; Innerárity A; Berisa A; Orjales A
    Drugs R D; 2005; 6(6):371-84. PubMed ID: 16274260
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Design, synthesis and biological activity evaluation of desloratadine analogues as H1 receptor antagonists.
    Lin Y; Wang Y; Sima LF; Wang DH; Cao XH; Chen LG; Chen B
    Bioorg Med Chem; 2013 Jul; 21(14):4178-85. PubMed ID: 23719280
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synthesis and antiallergic activity of some quinolinones and imidazoquinolinones.
    Peet NP; Baugh LE; Sunder S; Lewis JE
    J Med Chem; 1985 Mar; 28(3):298-302. PubMed ID: 2857792
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Design, synthesis and pharmacological screening of a series of N1-(substituted) aryl-5,7-dimethyl-2-(substituted)pyrido(2,3-d)-pyrimidin-4(3H)-ones as potential histamine H1-receptor antagonists.
    Suhagia BN; Chhabria MT; Makwana AG
    J Enzyme Inhib Med Chem; 2006 Dec; 21(6):681-91. PubMed ID: 17252940
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synthesis and antiallergy activity of N-[2-(dimethylamino)ethyl]-4-aryl-1-piperazinecarboxamide derivatives.
    Walsh DA; Green JB; Franzyshen SK; Nolan JC; Yanni JM
    J Med Chem; 1990 Jul; 33(7):2028-32. PubMed ID: 1972965
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Piperazine derivatives of dimethylxanthines. IV. Reaction of beta,gamma-epoxypropyldimethylxanthines with piperazines.
    Zejc A; Groczyca M; Kieć-Kononowicz K; Pawlowski M
    Pol J Pharmacol Pharm; 1976; 28(4):369-74. PubMed ID: 10560
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bioisosteric transformation of H1-antihistaminic benzimidazole derivatives.
    Iemura R; Hori M; Saito T; Ohtaka H
    Chem Pharm Bull (Tokyo); 1989 Oct; 37(10):2723-6. PubMed ID: 2575462
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dibenz[b,e]oxepin derivatives: novel antiallergic agents possessing thromboxane A2 and histamine H1 dual antagonizing activity. 1.
    Ohshima E; Takami H; Harakawa H; Sato H; Obase H; Miki I; Ishii A; Ishii H; Sasaki Y; Ohmori K
    J Med Chem; 1993 Feb; 36(3):417-20. PubMed ID: 8093908
    [No Abstract]   [Full Text] [Related]  

  • 29. An antihistamine compound with potent antibradykinin activity.
    Gecse A; Szekeres L; West GB
    J Pharm Pharmacol; 1969 Aug; 21(8):544-5. PubMed ID: 4389721
    [No Abstract]   [Full Text] [Related]  

  • 30. [Several antihistaminic pharmacodynamic aspects, especially of Eprozinol].
    Duchene-Marullaz P; Rispat G; Perriere JP
    Therapie; 1971; 26(1):155-62. PubMed ID: 4396627
    [No Abstract]   [Full Text] [Related]  

  • 31. Synthesis and structure-activity relationships of a new series of benzimidazoles as H1-antihistaminic agents.
    Cuberes MR; Contijoch M; Calvet C; Alegre J; Quintana JR; Frigola J
    Chem Pharm Bull (Tokyo); 1997 Aug; 45(8):1287-92. PubMed ID: 9301027
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Some pharmacodynamical properties of niaprazine, a new antihistaminic agent].
    Duchene-Marullaz P; Rispat G; Perriere JP; Hache J; Labrid C
    Therapie; 1971; 26(6):1203-9. PubMed ID: 4401719
    [No Abstract]   [Full Text] [Related]  

  • 33. Further studies on lidoflazine (R-7904).
    Türker RK; Kayaalp SO; Ozer A
    Arzneimittelforschung; 1968 Sep; 18(9):1209-12. PubMed ID: 4387885
    [No Abstract]   [Full Text] [Related]  

  • 34. Synthesis of 1,2-benzisothiazole derivatives and investigation of their putative histaminergic activity.
    Morini G; Pozzoli C; Adami M; Poli E; Coruzzi G
    Farmaco; 1999; 54(11-12):740-6. PubMed ID: 10668173
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Piperazine derivatives. 3. Effect of carbonyl- and hydroxy-derivatives (1)].
    Lányi K; Erdélyi I; Tardos L; Lovász M; Institoris E
    Pharmazie; 1970 Mar; 25(3):189-94. PubMed ID: 4393872
    [No Abstract]   [Full Text] [Related]  

  • 36. Synthesis and pharmacological activity of fluorescent histamine H1 receptor antagonists related to mepyramine.
    Li L; Kracht J; Peng S; Bernhardt G; Buschauer A
    Bioorg Med Chem Lett; 2003 Apr; 13(7):1245-8. PubMed ID: 12657255
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Synthesis and pharmacological evaluation of 5-dialkylaminomethyl-2-amino-2-oxazolines as H1-antagonists.
    Bosc JJ; Jarry C; Martinez B; Molimard M
    J Pharm Pharmacol; 2001 Jul; 53(7):923-7. PubMed ID: 11480540
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Conformationally restricted analogs of histamine H1 receptor antagonists. Trans- and cis-1,5-Diphenyl-3-dimethylaminopyrrolidine.
    Hanna PE; Ahmed AE
    J Med Chem; 1973 Sep; 16(9):963-8. PubMed ID: 4147659
    [No Abstract]   [Full Text] [Related]  

  • 39. Synthesis and antihistaminic activity of some thiazolidin-4-ones.
    Diurno MV; Mazzoni O; Piscopo E; Calignano A; Giordano F; Bolognese A
    J Med Chem; 1992 Jul; 35(15):2910-2. PubMed ID: 1353796
    [TBL] [Abstract][Full Text] [Related]  

  • 40. SYNTHESIS AND PHARMACOLOGICAL STUDY OF NEW PIPERAZINE DERIVATIVES. I. BENZYLPIPERAZINES.
    BOISSIER JR; RATOUIS R; DUMONT C
    J Med Chem; 1963 Sep; 6():541-4. PubMed ID: 14173578
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.